Bigelow S, Hough R, Rechsteiner M
Cell. 1981 Jul;25(1):83-93. doi: 10.1016/0092-8674(81)90233-6.
These studies use microinjection to determine whether the selective degradation of cytosolic proteins involves selective transfer of proteins to lysosomes or selective proteolysis within the cytosol. 14C-Sucrose-labeled bovine serum albumin (14C-sucBSA) was conjugated to polylysine, and monolayers of L929 cells were exposed to the conjugate. The 14C-sucrose-labeled peptides that arose upon degradation of the added 14C-sucBSA polylysine accumulated exclusively within lysosomes. In contrast, when 14C-sucBSA or 14C-sucrose-labeled pyruvate kinase (14C-sucPK) was microinjected into L929 cells, over half the 14C-sucrose-labeled peptides derived form the injected proteins were present in the postlysosomal supernatant. Control experiments demonstrated that the microinjection procedure did not cause 14C-sucrose peptides to leak from lysosomes. Therefore, the presence in the cytosol of substantial amounts of the degradation products from injected 14C-sucBSA and 14C-sucPK confirms the existence of a major proteolytic system(s) within or readily accessible to the cytosol of animal cells.
这些研究采用显微注射法来确定胞质蛋白的选择性降解是否涉及蛋白质向溶酶体的选择性转运或胞质内的选择性蛋白水解。将14C-蔗糖标记的牛血清白蛋白(14C-sucBSA)与聚赖氨酸偶联,然后将L929细胞单层暴露于该偶联物。添加的14C-sucBSA聚赖氨酸降解时产生的14C-蔗糖标记肽仅在溶酶体内积累。相反,当将14C-sucBSA或14C-蔗糖标记的丙酮酸激酶(14C-sucPK)显微注射到L929细胞中时,来自注射蛋白的超过一半的14C-蔗糖标记肽存在于溶酶体后的上清液中。对照实验表明,显微注射过程不会导致14C-蔗糖肽从溶酶体中泄漏。因此,注射的14C-sucBSA和14C-sucPK产生的大量降解产物存在于胞质中,这证实了动物细胞胞质内或易于进入胞质的主要蛋白水解系统的存在。